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Early embryonic development is known to be susceptible to maternal 
undernutrition, leading to a disease-related postnatal phenotype. To determine 
whether this sensitivity extended into oocyte development, we examined the 
effect of maternal normal protein diet (18% casein; NPD) or isocaloric low 
protein diet (9% casein; LPD) restricted to one ovulatory cycle (3.5 days) prior 
to natural mating in female MF-1 mice. After mating, all females received NPD 
for the remainder of gestation and all offspring were litter size adjusted and fed 
standard chow. No difference in gestation length, litter size, gender ratio or 
postnatal growth was observed between treatments. Maternal LPD did, however, 
induce abnormal anxiety-related behaviour in open field activities in male and 
female offspring (P <0.05). Maternal LPD offspring also exhibited elevated 
systolic blood pressure (SBP) in males at 9 and 15 weeks and in both genders at 
21 weeks (P <0.05). Male LPD offspring hypertension was accompanied by 
attenuated arterial responsiveness in vitro to vasodilators, acetylcholine and 
isoprenaline (P <0.05). LPD female offspring adult kidneys were also smaller, 
but had increased nephron numbers (P <0.05). Moreover, the relationship 
between SBP and kidney or heart size or nephron number was altered by diet 
treatment (P <0.05). These data demonstrate the sensitivity of mouse maturing 
oocytes in vivo to maternal protein undernutrition and identify both behavioural 
and cardiovascular postnatal outcomes, indicative of adult disease. These 
outcomes likely derive from a direct effect of protein restriction, although 
indirect stress mechanisms may also be contributory. Similar and distinct 
postnatal outcomes were observed here compared with maternal LPD treatment 
during post-fertilisation preimplantation development which may reflect the 
relative contribution of the paternal genome. 
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Introduction 
Recent studies have shown preimplantation mammalian development to be 
sensitive to both in vivo and in vitro environmental conditions resulting in altered 
blastocyst potential and long term changes in fetal and postnatal health and physiology 
(Thompson et al. 1995; Sinclair et al. 1999, 2007; Kwong et al. 2000; Ecker et al. 
2004; Fernandez-Gonzalez et al. 2004; Fleming et al. 2004; Sinclair and Singh, 2007; 
Watkins et al. 2007, 2008). This sensitivity in vivo may be explained by the 
‘Developmental Origins of Health and Disease’ (DOHaD) hypothesis which proposes 
that changes in the uterine environment mediated by maternal dietary quality induce 
responses within the embryo or fetus to match growth and metabolic phenotype to 
predicted postnatal nutrient availability. However, such responses may become 
maladaptive if predicted and actual nutrient levels are inconsistent, leading to adult 
onset cardiovascular and metabolic diseases (Gluckman & Hanson, 2004; McMillen & 
Robinson, 2005). Effects on developmental plasticity could also be induced in the 
periconceptual period, affecting oocyte maturation as well as embryo development, 
and this is the subject of the current study. 
 
In mammals, oocyte maturation is characterised by the resumption of meiosis, 
extrusion of the first polar body and re-organization of cytoplasmic constituents for 
fertilization. Acquisition of oocyte developmental competence does not occur in 
isolation, but is dependent upon the surrounding somatic cumulus cells with which 
there is a complex exchange of developmental signals mediated via gap junctions and 
diverse pathways including Kit, GDF (growth differentiation factor) and BMP (bone 
morphogenetic protein) components (Eppig, 2001; Amleh & Dean, 2002; Kidder & 
Mhawi, 2002; Richards et al. 2002; Thomas & Vanderhyden, 2006). Several studies 
have shown oocyte maturation to be sensitive to environmental conditions which may 
also have more long term developmental consequences. In vitro maturation of mouse, 
sheep and human oocytes reduces their viability and developmental competence 
(Eppig & Schroeder, 1989; Barnes et al. 1996; Mikkelsen et al. 1999; Bertolini et al. 
2002), resulting in altered fetal growth (Bertolini et al. 2002). In vivo, follicular 
growth and oocyte quality are affected by a range of dietary manipulations in 
domestic animals (Armstrong et al. 2001). Thus, dietary energy levels influence both 
follicle morphology and number and the composition of follicular fluid in ewes and 
heifers (Boland et al. 200; O’Callaghan et al. 2003), while increased protein and urea 
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intake and associated elevation in ammonia in follicular fluid result in reduced 
blastocyst development (McEvoy et al. 1997; Sinclair et al. 2000; Adamiak et al. 
2005; Powell et al. 2006). However, it is unclear from in vivo studies to date what the 
relative sensitivity of oocyte or embryo environments might be to periconceptual 
dietary challenge maintained both before and after mating (Edwards & McMillen, 
2002: Sinclair et al. 2007). In contrast, the embryo environment in vivo has been 
clearly demonstrated to be sensitive to maternal diet restriction (Kwong et al. 2000; 
Watkins et al. 2008). 
 
Using a mouse model with large sample size, we have investigated the effect 
of maternal dietary protein restriction during oocyte maturation on postnatal growth, 
behaviour and cardiovascular physiology. We have found that maternal low protein 
diet (LPD) provided exclusively during oocyte maturation has minimal effects on 
postnatal growth but results in abnormal anxiety-related behaviour, elevated systolic 
blood pressure, reduced vascular responsiveness and altered kidney allometry and 
organization. Our results indicate firstly that oocyte maturation is a sensitive period 
with respect to maternal diet and onset of adult disease, and secondly that the oocyte 
and early embryo exhibit common and distinct environmental susceptibilities that may 
derive from the presence or absence of the paternal genome. 
 
Methods 
Animal treatments.  These were conducted using protocols approved by UK Home 
Office and local ethics committee. Female MF-1 mice were bred in-house (University 
of Southampton Biomedical Research Facility) and maintained on 0700-1900 hour 
light cycle with controlled temperature and standard chow and water ad libitum. 
Vaginal smears were taken from virgin females (7-8.5 weeks) to determine metoestrus 
at which point females were singly caged and randomly assigned either normal 
protein diet (NPD; 18% casein) or isocaloric low protein diet (LPD; 9% casein; 
Kwong et al. 2000; Watkins et al. 2008). After 3.5 days, females were mated 
overnight with MF-1 males (Harlan). Plug positive females were placed on NPD and 
individually housed for the remainder of gestation whilst plug negative females were 
removed from the study. In total, nineteen females of each dietary treatment (NPD 
and LPD) were allowed to develop their pregnancies to term, at which time all 
animals were returned to standard chow. Offspring were weighed on day of birth and 
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weekly for up to 28 weeks. Where possible, litter size was adjusted at birth to six 
(three males and three females). At 3 weeks, offspring were weaned and the sexes 
caged separately. Animal coding allowed for all outcome analyses to be conducted 
‘blind’ to ensure objectivity. 
 
Behaviour. At 4, 5, 6, 8, 11, 14, 17 and 20 weeks, offspring were subjected to 
species-specific locomotory, anxiety-related (open field) and affective (burrowing, 
nesting, glucose solution consumption) activity tests as previously described 
(Guenther et al. 2001; Cunningham et al. 2003; Cunningham et al. 2007; Watkins et 
al. 2008). Weeks 4-6 were taken as acclimatory and weeks 8-20 as assay tests. The 
illuminated open field (white PVC arena, 30 cm2) test comprised 3 minute 
observations with automated recording of total distance travelled, number of hind 
rears, jumps, time spent resting and average velocity. 
 
Systolic blood pressure (SBP). SBP was determined at 9, 15 and 21 weeks by tail-
cuff plethysmography as previously described (Watkins et al. 2006). Briefly, mice 
were allowed to acclimatize to 27-30oC before four recordings were taken per mouse; 
heart rate was monitored as an indicator of stress (Langley-Evans et al. 1996). 
 
Mesenteric vasoreactivity. Vascular function in male offspring was assessed at 22 
weeks in isolated small mesenteric arteries following cervical dislocation. The 
mesenteric arcade was excised and immersed in physiological salt solution (PSS; 
Torrens et al. 2003) at 4oC. Small mesenteric arteries (luminal diameter ca. 100-300 
µm) were dissected free of connective tissue and mounted in PSS on a wire myograph 
(Multi Myograph Model 610M; JP Trading, Aarhus, Denmark) for analysis of 
isometric tension as described previously (Brawley et al. 2003; Torrens et al. 2003; 
Torrens et al. 2006). Briefly, following normalisation, cumulative concentration 
response curves (CRCs) were measured for the α1-adrenergic agonist, phenylephrine 
(PE; 10-9 to 10-4 M). Vessels were then pre-constricted with a submaximal dose of PE 
(EC80) and CRCs to the endothelium-dependent vasodilator, acetylcholine (ACh; 10-9 
to 10-5 M), the β-adrenoceptor agonist, isoprenaline (ISO; 10-10 to 10-6 M) and the 
endothelium-independent vasodilator, sodium nitroprusside (SNP; 10-11 to 10-5 M) 
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were conducted in that order. All drugs were purchased from Sigma (Poole, Dorset, 
UK). 
 
Kidney nephron counting. At 28 weeks, female mice were terminally anaesthetized 
by an intraperitoneal injection of a ketamine (Fort Dodge) acepromazine (C-Vet) 
anaesthetic followed by thoracotomy. A butterfly needle (Venisystems, Butterfly -23 
ST) was inserted into the left ventricle and the vena cava was cut. Mice were perfused 
with ~15 ml heparinized saline (0.5 units/ml saline, Sigma) at a mean pressure of 100 
mm Hg to prevent clot formation in the kidney, followed by ~15 ml neutral buffered 
formalin (Gurr). Left kidneys were removed and immersion fixed in formalin for 48 
hours, followed by overnight dehydration through graded alcohols (Leica TP 1020 
tissue processor). Each kidney was cut into eight pieces (left/right, anterior/posterior 
and dorsal/ventral portions) and processed into glycol methacrylate (JB-4 Embedding 
Kit; Polysciences Europe GmbH, Germany). In preliminary studies, the two blocks 
comprising anterior, dorsal, left and right kidney pieces were found not to differ 
significantly in nephron number from the remaining six blocks and were subsequently  
used as representative of the entire kidney. These blocks were exhaustively sectioned 
at 2 µm using an ultramicrotome (R. Jung Heidelberg). Every 100th and 110th section 
was mounted and stained with toluidine blue (1% toluidine blue w/v in 1% sodium 
tetra borate w/v in distilled water) for approximately 5-10 seconds, dried and cover 
slipped with DPX (Gurr). Unbiased stereological counting was carried out using 
Stereo Investigator (Microbrightfield, Williston, VT) software connected to a Dialux 
22 microscope (Leica) with a motorized x-y-z stage (Ludl, Hawthorne, NY) and a 
DEI-750D video camera (Optronics, Goleta, CA). An unbiased counting frame (500 
µm square) was randomly place over the 100th section and glomeruli within or 
touching the inclusion lines were counted. The trace was then overlaid on the 110th 
section and glomeruli present here but absent from the 100th section were counted.  
On average, 10-15 pairs of sections were analysed per block and an estimate of 
kidney glomerular number was obtained using the fractionator principle (Bertram, 
2005). 
 
Angiotensin converting enzyme (ACE) activity.  Serum and lung ACE activity were 
analysed as previously described (Watkins et al. 2006; Watkins et al. 2007). Briefly, 
serum samples were incubated in the presence of hippuryl-L-histidine-L-leucine 
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acetate salt (HHLA; Sigma) solution in phosphate buffer at 37oC followed by addition 
of cyanuric chloride (Sigma, Poole, Dorset, UK) in 1,4 dioxane (Sigma, Poole, 
Dorset, UK). Four replicates per sample were analysed on a Dynex MRX2 plate 
reader at 380 nm. Samples containing only serum and buffer were used as negative 
controls. Sample readings were analysed against a standard curve prepared in buffer 
and treated exactly as the samples. Serum ACE activity was expressed as nanomoles 
of hippurate formed per ml-1 serum per minute; 15-17 samples per treatment group 
were analysed. The intra- and inter-assay variation was 3.88% and 17.1% 
respectively. 
 
Lung tissue (approximately 50 mg) was homogenized in buffer, centrifuged and the 
supernatant removed and stored.  The pellets were homogenised a second time and 
the supernatants removed after centrifugation as before. Samples of each extract were 
mixed with buffer, water and hippuryl-L-histidine-L-leucine acetate salt (Sigma, 
Poole, Dorset, UK). Negative controls included the addition of HCl prior to addition 
of the hippuryl-L-histidine-L-leucine. Samples and blanks were incubated at 37oC 
prior to the addition of HCl, NaOH, KH2PO4 and cyanuric chloride. Sample readings 
were analysed against a standard curve prepared in buffer and treated exactly as the 
samples. Samples were analysed in duplicate on a Dynex MRX2 plate reader at 380 
nm, and an average activity taken. Tissue protein content was measured using the 
Bio-Rad protein assay kit. Tissue ACE activity was expressed as nanomoles hippurate 
formed per mg of protein per minute. The intra- and inter-assay variation was 16.9% 
and 22% respectively. 
 
Organ allometry. At 28 weeks, following cervical dislocation, blood samples were 
removed via heart puncture and liver, left and right kidneys, heart, lungs and brain 
were dissected, weighed, and snap frozen in liquid nitrogen and stored at -80oC.  
 
Statistical analyses. Student’s t-test was used to analyse mean gestational litter size 
and male:female ratio (SigmaStat statistical software, version 3.5). Vascular 
responsiveness data (cumulative concentration response curves) were analysed using 
2-way ANOVA (Prism 3.0, GraphPad Software Inc) as previously (Torrens et al. 
2003; Torrens et al. 2006). All other postnatal data (birth weight, postnatal weights, 
behavioural data, SBP, organ weights and ratios, kidney glomerular number and 
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correlations) were analysed using a multilevel random effects regression model (SPSS 
version 14) which takes into account the hierarchical nature of the data with between-
mother and within-mother variation and different parameters measured from 
individual animals (Kwong et al. 2004; Watkins et al. 2006). Thus, differences 
identified between treatment groups throughout the study are independent of maternal 
origin of litter, gestational litter size, body weight, unless otherwise stated. Week of 
testing was included into the analysis of the behavioural data. 
 
Results 
Litter size, birth weight and postnatal growth. Gestation length, gestational litter 
size and offspring gender ratio were not significantly different between dietary groups 
(Table 1). LPD males displayed a trend towards elevated mean birth weight when 
compared to NPD males (Fig. 1; P =0.073) independent of gestational litter size and 
gender ratio. No difference in birth weight was observed between female groups. No 
difference in mean weekly weight was evident between treatment groups up to 28 
weeks (Fig. 2 A, B). 
 
Behaviour. When examined on an individual week basis, LPD males displayed 
reduced distance travelled at 14, 17 and 20 weeks (reduced by 37.4, 54 and 40.5% 
respectively vs NPD; all P <0.03), and increased time resting at 17 weeks (by 9.1 % 
vs NPD; P =0.039) compared to NPD males. LPD females also displayed reduced 
distance travelled at 20 weeks (by 38.4%; P = 0.037), reduced numbers of rears at 8, 
11, 14 and 20 weeks (by 36.7, 35.94, 41.4 and 49.8% vs NPD: P <0.035), reduced 
numbers of jumps at 8, 14 and 20 weeks (by 48.3, 69.74, 89.3% vs NPD; P <0.05), 
increased time resting at 14, 17 and 20 weeks (by 5.0, 2.8, 8.4% vs NPD; P = <0.05) 
and increased velocity at 11 weeks (by 41.2%; P = 0.042). All differences were 
independent of maternal origin and gestational litter size. Integration of all weekly 
data into mean open field activities, taking into account week of testing, showed that 
the male LPD offspring displayed reduced mean distance travelled, number of rears 
and jumps, increased velocity (P <0.005), and a trend towards an increased time spent 
resting (Fig 3A; P =0.071). LPD females also displayed reduced distance travelled, 
mean number of rears and jumps, increased time resting and increased velocity 
compared to NPD females (Fig. 3B; P <0.01). Analysis of affective behaviour showed 
LPD females displayed a trend towards increased burrowing activity after 2 hours and 
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overnight (by 16.5 and 5.7% respectively vs NPD; P = 0.096 and 0.087), however, no 
differences were observed between treatment groups for either glucose solution 
consumption or in nest construction (data not shown).  
 
Systolic blood pressure. Mean systolic blood pressure (SBP) of offspring was 
determined at 9, 15 and 21 weeks, with the mean of these values recorded as ‘Life 
SBP’ (Fig. 4 A, B). LPD males displayed elevated SBP at all assay times (4.23 % 
higher Life SBP than NPD; P =0.002; Fig. 4A) whilst LPD females had a trend 
towards a higher SBP at 15 weeks (P = 0.09) and significantly higher SBP at 21 
weeks and for Life SBP (2.88 % higher Life SBP than NPD; P = 0.01; Fig. 4B). 
Whilst these data were independent of maternal origin and body weight, gestational 
litter size positively influenced 21 week SBP in males (+1.11 mm Hg per value 
increase in litter size, P = 0.034), and Life SBP in females (+0.68 mm Hg per value 
increase in litter size, P = 0.014). 
 
Mesenteric artery vasoreactivity 
The α1-adrenergic agonist, PE, produced a concentration-dependent vasoconstriction 
which was similar in LPD and NPD males (Fig. 5A). Vasodilatation to the 
endothelium-dependent vasodilator, ACh, and the β-adrenoceptor agonist, ISO, in PE-
preconstricted arteries was attenuated in the LPD group (Fig. 5B, C; P =0.001 and 
0.014 respectively). Dilatation to the endothelium-independent vasodilator, SNP, was 
similar between the two groups (Fig. 5D). 
 
Organ allometry.  No differences in organ weights (liver, kidney, heart, lung, brain 
and cerebellum) or organ:body weight ratios were evident between LPD and NPD 
males at 28 weeks (Table 2A). However, LPD females had reduced right (Table 2B; P 
= 0.031) and combined (data not shown; P = 0.044) kidney:body weight ratios 
compared to NPD females. A positive correlation was present between both left and 
right kidney:body weight ratios and Life SBP in LPD males (Fig. 6A, B; P <0.007), 
different (P <0.015) to NPD males which showed no correlation between these 
factors. LPD males also displayed a positive correlation between heart:body weight 
ratio and Life SBP (Fig. 6C; P =0.004), different from NPD males (P =0.05) which 
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showed no correlation between these factors. All differences were independent of 
maternal origin and gestational litter size. 
 
Kidney nephron counts. Morphometric analysis of left kidney glomerular number in 
female offspring at 28 weeks revealed increased numbers within the LPD group 
(28.1% higher than NPD;  P = 0.03; Fig. 7A). When mean glomerular number was 
expressed as per gm or cm3 of kidney tissue, LPD kidneys demonstrated a significant 
increase and a trend towards an increased glomerular number respectively (32.8 and 
35.1% higher than NPD; P =0.031 and 0.091 respectively; Fig. 7A). Whilst these data 
were independent of gestational litter size and kidney weight effects, when mean 
glomerular number/cm3 was analysed independently of litter size, a significant 
increase was observed for the LPD group (P =0.036). Analysis of glomerular 
number:Life SBP correlation revealed the LPD group to have a negative correlation 
(r2 =-0.902, P =0.007), whilst the NPD group displayed no correlation (r2 =0.382, P 
=0.228; Fig. 7B). 
 
Angiotensin converting enzyme (ACE) activity. No difference in serum ACE 
activity was observed between NPD and LPD males (126.22 ± 14.30 and 146.53 ± 
14.19 nanomoles hippurate respectively, P >0.05), or females (81.14 ± 8.00 and 
105.17 ± 12.53 nanomoles hippurate respectively, P >0.05, data not shown). No 
difference in lung ACE activity was observed between NPD and LPD males (3.25 ± 
0.52 and 3.11 ± 0.48 nanomoles hippurate respectively, P >0.05) or females (3.30 ± 
0.38 and 3.45 ± 0.67 nanomoles hippurate respectively, P<0.05, data not shown).  
 
Discussion 
 Collectively, our data demonstrate that maternal LPD treatment exclusively 
during mouse oocyte maturation (3.5 days prior to conception) is sufficient to alter 
postnatal phenotype resulting in behavioural and cardiovascular changes indicative of 
adult disease. These findings, together with those previously identified by maternal 
protein restriction exclusively during preimplantation development (Kwong et al. 
2000; Watkins et al. 2008), or during both pre- and post fertilisation periods  
(Edwards & McMillen, 2002: Sinclair et al. 2007), provide strong support for the 
DOHaD hypothesis and the vulnerability of the periconceptual period, including that 
of oocyte maturation, to environmental conditions. 
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Analysis of postnatal behavioural outcomes revealed predominant effects 
induced by LPD treatment during oocyte maturation, on both male and female 
offspring. These included altered open field activity, notably reduced exploratory 
behaviour (distance travelled, rearing, jumping), increased time spent resting, and 
increased velocity. Behavioural testing for species-typical spontaneous activities as 
used here provide sensitive assays of well-being, devised to identify a mild sickness 
phenotype in murine prion and related disease models prior to the detection of clinical 
biochemical symptoms (Guenther et al. 2001; Cunningham et al. 2003; Cunningham 
et al. 2007). The reduced exploratory activity and longer rest periods are difficult to 
interpret in isolation but these deficits signify reduced responsiveness to 
environmental stimuli which may associate with increased anxiety and/or a change in 
affective behaviour (Guenther et al. 2001; Cunningham et al. 2003; Cunningham et 
al. 2007). Altered postnatal open field activity has also been identified, especially in 
females, in response to maternal LPD restricted to the preimplantation period, further 
indicating the importance of periconceptual dietary environment on adult behaviour 
(Watkins et al. 2008). 
 
The second major change in phenotype detected in offspring following 
maternal LPD treatment during oocyte maturation is associated with the 
cardiovascular system. Male and female LPD offspring developed relative 
hypertension with females showing delay in its inception but, in both sexes, Life SBP 
was elevated significantly. We believe this is the first report to demonstrate 
hypertension associated with maternal protein restriction during the period of oocyte 
maturation alone, although LPD treatment during pregnancy or limited to the 
preimplantation period has been shown previously to lead to raised SBP in rodent 
models (Langley & Jackson, 1994; Kwong et al. 2000; Fleming et al. 2004; 
Gluckman & and Hanson, 2004; McMillen & Robinson, 2005; Sinclair & Singh, 
2007; Watkins et al. 2008). The origins of hypertension using these models for 
gestational diet restriction, together with domestic animal models, appear complex 
and may involve alteration to the hypothalamic-pituitary-adrenal (HPA) axis and the 
renin-angiotensin system during fetal development leading to loss of normal 
cardiovascular control and peripheral vessel dysfunction (Brawley et al. 2003; 
Torrens et al. 2003; Fleming et al. 2004; Gluckman & and Hanson, 2004; McMillen 
& Robinson, 2005; Torrens et al. 2006).  
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To interpret the potential contributory components of hypertension in LPD 
offspring, we examined arterial vessel responsiveness to both vasoconstrictors and 
endothelium-dependent and –independent vasodilatators in male offspring. We found 
that mesenteric arteries from LPD animals displayed attenuated dilatation to ACh and 
ISO. Such effects have been shown to associate with aspects of cardiovascular disease 
in the rat following maternal LPD during pregnancy (Brawley et al. 2003; Torrens et 
al. 2003; Torrens et al. 2006). These data indicate that reduced vascular 
responsiveness in males may be mediated through endothelial-dependent 
mechanisms, possibly associated with nitric oxide and/or β-adrenoceptor pathways 
(Brawley et al. 2003; Torrens et al. 2003; Torrens et al. 2006).  
 
Our other studies to evaluate cardiovascular phenotype have focused on the 
female kidney, which has been shown to be reduced in size with reduced nephron 
number as a result of gestational maternal diet restriction in several species (Zandi-
Nejad et al. 2006; Bagby, 2007), including the mouse (Hoppe et al. 2007). 
Compromised kidney development during late gestation may reflect a fetal ‘strategy’ 
to protect vital organ development such as the brain and heart at the expense of 
abdominal organs in response to restricted nutrient availability (McMillen and 
Robinson, 2005; Bagby, 2007). Whilst reduced kidney growth or body weight in 
offspring coincides with reduced nephron number and hypertension in several 
(Langley-Evans et al. 1999; Bagby, 2007) but not all (Woods et al. 2005) models of 
gestational diet restriction, our findings are unusual in that maternal LPD female 
offspring exhibited reduced kidney size coupled with increased nephron number. 
These changes in kidney size also altered the relationship with Life SBP. Given that 
kidney development occurs late in gestation and that our dietary challenge actually 
precedes the initiation of the developmental programme, it is possible that the kidney 
phenotype of increased nephron number may reflect a compensatory response to the 
maternal challenge. Indeed, the negative correlation observed between Life SBP and 
kidney nephron number identified in the female LPD group supports this contention. 
However, further molecular and biochemical studies on kidney morphogenesis and 
postnatal function in response to protein restriction during oocyte maturation are 
required to interpret more fully the kidney phenotype and its relationship with 
cardiovascular health.  
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The diverse outcomes identified in offspring following maternal LPD during 
oocyte maturation indicate that nutrition prior to conception is critical in the setting of 
homeostatic regulators affecting health and disease risk. Whilst the discrete nature of 
the dietary challenge allows us to focus on the health implications for a specific 
period of the reproductive cycle, and also to make comparisons between different 
periods (discussed below), we need to consider two alternative interpretations of our 
outcomes. First, the outcomes may also reflect a persistence of the dietary challenge 
on maternal environment and physiology beyond that of oocyte maturation into early 
development. Second, the outcomes may also reflect changes in maternal environment 
induced by the stress of the diet change itself. We cannot exclude either of these 
factors contributing to outcomes but, nevertheless, it would be reasonable to conclude 
that even if they were, then a changed diet during oocyte maturation would still be the 
upstream mediator, a factor pertinent in any extrapolation to the human situation and 
the importance of dietary practice prior to conception. However, we feel that these 
two indirect components are likely to be minimal for the following reasons. First, in 
our previous mouse diet analysis focusing on the preimplantation period (Watkins et 
al. 2008), the outcomes identified compared to here were distinct but with some 
shared responses (discussed below) suggesting that the discrete nature of the 
challenges were having specific effects at that time rather than persisting longer. 
Second, in that study, embryo transfer was conducted of LPD embryos into NPD 
recipients to test directly whether a persistent effect on the maternal environment was 
contributory to outcomes. This revealed that the LPD-induced effect on the embryo 
was preserved in the absence of a maternal LPD environment after transfer, 
confirming the derivation of the outcome to maternal diet during preimplantation 
development. Whilst a similar strategy of analysing embryo transfers in the current 
study would notionally confirm the origin of our findings, and will be considered for 
future studies, the transfer procedure and in vitro treatment involved may generate 
confounding stress-related responses as these would need to be conducted on the stage 
immediately following oocyte maturation, the period of fertilisation-mediated 
signalling of embryonic genome activation known for its environmental sensitivity 
(Gardner and Lane, 1996; Qiu et al. 2003). Indeed, in an earlier study where we 
investigated the effects of embryo culture on postnatal outcomes, blastocyst transfer 
itself was found to affect outcomes but minimally compared to the embryo culture 
challenge (Watkins et al. 2007).   
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Comparison of the postnatal phenotypes induced in mice in response to 
maternal LPD experienced during oocyte maturation here with that during 
preimplantation embryo development (Watkins et al. 2008) gives further insight into 
potential mechanisms. Whilst hypertension in male and female offspring and 
behavioural changes, predominantly in female offspring, are evident in both models, 
the major distinction is in the effect on fetal and postnatal growth, only evident in 
response to maternal LPD during preimplantation development (Watkins et al. 2008). 
Whilst, in the current study, we are challenging a different phase in the reproductive 
cycle (gamete versus preimplantation embryo development), and therefore cannot 
discount the effect this may have upon postnatal development, one important 
distinction between the two models is the presence of the paternal genome at the time 
of dietary challenge during the preimplantation period. Genomic imprinting has been 
identified a critical role in controlling growth of the conceptus during pregnancy by, 
for example, modulating placental efficiency for maternal-fetal nutrient delivery and 
coordinating growth factor ligand-receptor interactions (Angiolini et al. 2006; Smith 
et al. 2006). Thus, paternal and maternal alleles of imprinted genes may confer 
opposing effects in such mechanisms, reflecting the need for the paternal genome to 
promote fetal growth and the maternal genome to temper this to protect maternal 
health for later pregnancies. The ‘conflict hypothesis’ embodies these divergent 
genomic strategies (Angiolini et al. 2006; Smith et al. 2006). Changes in the 
expression (but to date not changes in DNA methylation status) of imprinted genes 
have been identified in preimplantation embryos and their derivative tissues in 
response to maternal LPD (Kwong et al. 2006). Moreover, changes in expression 
and/or DNA methylation status of imprinted genes have been shown following 
embryo in vitro culture treatments (Doherty et al. 2000; Khosla et al. 2001; Young et 
al. 2001; Mann et al. 2004). Thus, the distinct effects on growth control mediated by 
maternal LPD during oocyte maturation versus preimplantation development may 
reflect differential effects on the paternal genome.  
In conclusion, we show that oocyte maturation in mice is sensitive in vivo to 
maternal dietary protein level with behavioural and cardiovascular markers of 
postnatal health being adversely affected in conditions of protein undernutrition. 
These novel findings support the contention that periconceptual environment 
including both before and after fertilization, and both in vitro and in vivo, associates 
 15 
with adult health and disease risk. Whilst our data here using an animal model cannot 
be extrapolated directly to the human, we consider animal models as useful in 
identifying potential relationships that merit separate investigation across species 
including the human. Given that preimplantation programming of adult disease has 
been shown to comprise a complex of mechanisms acting at epigenetic, physiological 
and cellular levels (Fernandez-Gonzalez et al. 2004), further studies are required to 
elucidate how oocyte maturation may be affected by maternal diet with such long-
lasting consequences. 
 
Acknowledgements   
This work was supported by the National Institutes of Health, USA as part of the 
NICHD National Cooperative Program on Female Health and Egg Quality under 
cooperative agreement U01 HD044635, and the Gerald Kerkut Charitable Trust. 
MAH is supported by the British Heart Foundation. We thank Rebecca Brennan for 
assistance in kidney nephron counting and the Biomedical Facility, University of 
Southampton, for their technical support. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 16 
References 
 
Adamiak SJ, Mackie K, Watt RG, Webb R & Sinclair KD (2005). Impact of nutrition 
on oocyte quality: cumulative effects of body composition and diet leading to 
hyperinsulinemia in cattle. Biol Reprod 73, 918-926. 
 
Amleh A & Dean J (2002). Mouse genetics provides insight into folliculogenesis, 
fertilization and early embryonic development. Hum Reprod Update 8, 395-403. 
 
Angiolini E, Fowden A, Coan P, Sandovici I, Smith P, Dean W, Burton G, Tycko B, 
Reik W, Sibley C & Constancia M (2006). Regulation of placental efficiency for 
nutrient transport by imprinted genes. Placenta 27 Suppl A, S98-102. 
 
Armstrong DG, McEvoy TG, Baxter G, Robinson JJ, Hogg CO, Woad KJ, Webb R & 
Sinclair KD (2001). Effect of dietary energy and protein on bovine follicular 
dynamics and embryo production in vitro: associations with the ovarian insulin-like 
growth factor system. Biol Reprod 64, 1624-1632. 
 
Bagby SP (2007). Maternal nutrition, low nephron number, and hypertension in later 
life: pathways of nutritional programming. J Nutr 137, 1066-1072. 
 
Barnes FL, Kausche A, Tiglias J, Wood C, Wilton L & Trounson A (1996). 
Production of embryos from in vitro-matured primary human oocytes. Fertil Steril 65, 
1151-1156. 
 
Bertolini M, Mason JB, Beam SW, Carneiro GF, Sween ML, Kominek DJ, Moyer 
AL, Famula TR, Sainz RD & Anderson GB (2002). Morphology and morphometry of 
in vivo- and in vitro-produced bovine concepti from early pregnancy to term and 
association with high birth weights. Theriogenology 58, 973-994. 
 
Bertram JF (1995). Analyzing renal glomeruli with the new stereology. Int Rev Cytol 
161, 111-172. 
 
 17 
Boland MP, Lonergan P & O'Callaghan D (2001). Effect of nutrition on endocrine 
parameters, ovarian physiology, and oocyte and embryo development. 
Theriogenology 55, 1323-1340. 
 
Brawley L, Itoh S, Torrens C, Barker A, Bertram C, Poston L & Hanson M (2003). 
Dietary protein restriction in pregnancy induces hypertension and vascular defects in 
rat male offspring. Pediatr Res 54, 83-90. 
 
Cunningham C, Campion S, Teeling J, Felton L & Perry VH (2007). The sickness 
behaviour and CNS inflammatory mediator profile induced by systemic challenge of 
mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 21, 490-
502. 
 
Cunningham C, Deacon R, Wells H, Boche D, Waters S, Diniz CP, Scott H, Rawlins 
JN & Perry VH (2003). Synaptic changes characterize early behavioural signs in the 
ME7 model of murine prion disease. Eur J Neurosci 17, 2147-2155. 
 
Doherty AS, Mann MR, Tremblay KD, Bartolomei MS & Schultz RM (2000). 
Differential effects of culture on imprinted H19 expression in the preimplantation 
mouse embryo. Biol Reprod 62, 1526-1535. 
 
Ecker DJ, Stein P, Xu Z, Williams CJ, Kopf GS, Bilker WB, Abel T & Schultz RM 
(2004). Long-term effects of culture of preimplantation mouse embryos on behavior. 
Proc Natl Acad Sci USA 101, 1595-1600. 
 
Edwards LJ & McMillen IC (2002). Periconceptional nutrition programs development 
of the cardiovascular system in the fetal sheep. Am J Physiol Regul Integr Comp 
Physiol 283, R669-R679. 
 
Eppig JJ (2001). Oocyte control of ovarian follicular development and function in 
mammals. Reproduction 122, 829-838. 
 
 18 
Eppig JJ & Schroeder AC (1989). Capacity of mouse oocytes from preantral follicles 
to undergo embryogenesis and development to live young after growth, maturation, 
and fertilization in vitro. Biol Reprod 41, 268-276. 
 
Fernandez-Gonzalez R, Moreira P, Bilbao A, Jimenez A, Perez-Crespo M, Ramirez 
MA, Rodriguez DF, Pintado B & Gutierrez-Adan A (2004). Long-term effect of in 
vitro culture of mouse embryos with serum on mRNA expression of imprinting genes, 
development, and behavior. Proc Natl Acad Sci USA 101, 5880-5885. 
 
Fleming TP, Kwong WY, Porter R, Ursell E, Fesenko I, Wilkins A, Miller DJ, 
Watkins AJ & Eckert JJ (2004). The embryo and its future. Biol Reprod 71, 1046-
1054. 
 
Gardner DK & Lane M (1996). Alleviation of the '2-cell block' and development to 
the blastocyst of CF1 mouse embryos: role of amino acids, EDTA and physical 
parameters. Hum Reprod 11, 2703-2712. 
 
Gluckman PD & Hanson MA (2004). Living with the past: evolution, development, 
and patterns of disease. Science 305, 1733-1736. 
 
Guenther K, Deacon RM, Perry VH & Rawlins JN (2001). Early behavioural changes 
in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 14, 401-409. 
 
Hoppe CC, Evans RG, Bertram JF & Moritz KM (2007). Effects of dietary protein 
restriction on nephron number in the mouse. Am J Physiol Regul Integr Comp Physiol 
292, R1768-R1774. 
 
Khosla S, Dean W, Reik W & Feil R (2001). Culture of preimplantation embryos and 
its long-term effects on gene expression and phenotype. Hum Reprod Update 7, 419-
427. 
 
Kidder GM & Mhawi AA (2002). Gap junctions and ovarian folliculogenesis. 
Reproduction 123, 613-620. 
 
 19 
Kwong WY, Miller DJ, Ursell E, Wild AE, Wilkins AP, Osmond C, Anthony FW & 
Fleming TP (2006). Imprinted gene expression in the rat embryo-fetal axis is altered 
in response to periconceptional maternal low protein diet. Reproduction 132, 265-277. 
 
Kwong WY, Osmond C & Fleming TP (2004). Support for Barker hypothesis upheld 
in rat model of maternal undernutrition during the preimplantation period: application 
of integrated 'random effects' statistical model. Reprod Biomed Online 8, 574-576. 
 
Kwong WY, Wild AE, Roberts P, Willis AC & Fleming TP (2000). Maternal 
undernutrition during the preimplantation period of rat development causes blastocyst 
abnormalities and programming of postnatal hypertension. Development 127, 4195-
4202. 
 
Langley SC & Jackson AA (1994). Increased systolic blood pressure in adult rats 
induced by fetal exposure to maternal low protein diets. Clin Sci (Lond) 86, 217-222. 
 
Langley-Evans SC, Gardner DS & Jackson AA (1996). Association of 
disproportionate growth of fetal rats in late gestation with raised systolic blood 
pressure in later life. J Reprod Fertil 106, 307-312. 
 
Langley-Evans SC, Welham SJ & Jackson AA (1999). Fetal exposure to a maternal 
low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci 
64, 965-974. 
 
Mann MR, Lee SS, Doherty AS, Verona RI, Nolen LD, Schultz RM & Bartolomei 
MS (2004). Selective loss of imprinting in the placenta following preimplantation 
development in culture. Development 131, 3727-3735. 
 
McEvoy TG, Robinson JJ, Aitken RP, Findlay PA & Robertson IS (1997). Dietary 
excesses of urea influence the viability and metabolism of preimplantation sheep 
embryos and may affect fetal growth among survivors. Anim Reprod Sci 47, 71-90. 
 
McMillen IC & Robinson JS (2005). Developmental origins of the metabolic 
syndrome: prediction, plasticity, and programming. Physiol Rev 85, 571-633. 
 20 
 
Mikkelsen AL, Smith SD & Lindenberg S (1999). In-vitro maturation of human 
oocytes from regularly menstruating women may be successful without follicle 
stimulating hormone priming. Hum Reprod 14, 1847-1851. 
 
O'Callaghan D, Yaakub H, Hyttel P, Spicer LJ & Boland MP (2000). Effect of 
nutrition and superovulation on oocyte morphology, follicular fluid composition and 
systemic hormone concentrations in ewes. J Reprod Fertil 118, 303-313. 
 
Powell K, Rooke JA, McEvoy TG, Ashworth CJ, Robinson JJ, Wilmut I, Young LE 
& Sinclair KD (2006). Zygote donor nitrogen metabolism and in vitro embryo culture 
perturbs in utero development and IGF2R expression in ovine fetal tissues. 
Theriogenology 66, 1901-1912. 
 
Qiu JJ, Zhang WW, Wu ZL, Wang YH, Qian M, & Li YP (2003). Delay of ZGA 
initiation occurred in 2-cell blocked mouse embryos. Cell Res 13, 179-185. 
 
Richards JS, Russell DL, Ochsner S & Espey LL (2002). Ovulation: new dimensions 
and new regulators of the inflammatory-like response. Annu Rev Physiol 64, 69-92. 
 
Sinclair KD, McEvoy TG, Maxfield EK, Maltin CA, Young LE, Wilmut I, Broadbent 
PJ & Robinson JJ (1999). Aberrant fetal growth and development after in vitro culture 
of sheep zygotes. J Reprod Fertil 116, 177-186. 
 
Sinclair KD, Kuran M, Gebbie FE, Webb R & McEvoy TG (2000). Nitrogen 
metabolism and fertility in cattle: II. Development of oocytes recovered from heifers 
offered diets differing in their rate of nitrogen release in the rumen. J Anim Sci 78, 
2670-2680. 
 
Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, Thurston 
A, Huntley JF, Rees WD, Maloney CA, Lea RG, Craigon J, McEvoy TG, & Young 
LE (2007). DNA methylation, insulin resistance, and blood pressure in offspring 
determined by maternal periconceptional B vitamin and methionine status. Proc Natl 
Acad Sci U S A 104, 19351-19356. 
 21 
Sinclair KD & Singh R (2007). Modelling the developmental origins of health and 
disease in the early embryo. Theriogenology 67, 43-53. 
 
Smith FM, Garfield AS & Ward A (2006). Regulation of growth and metabolism by 
imprinted genes. Cytogenet Genome Res 113, 279-291. 
 
Thomas FH & Vanderhyden BC (2006). Oocyte-granulosa cell interactions during 
mouse follicular development: regulation of kit ligand expression and its role in 
oocyte growth. Reprod Biol Endocrinol 4, 19. 
 
Thompson JG, Gardner DK, Pugh PA, McMillan WH & Tervit HR (1995). Lamb 
birth weight is affected by culture system utilized during in vitro pre-elongation 
development of ovine embryos. Biol Reprod 53, 1385-1391. 
 
Torrens C, Brawley L, Anthony FW, Dance CS, Dunn R, Jackson AA, Poston L & 
Hanson MA (2006). Folate supplementation during pregnancy improves offspring 
cardiovascular dysfunction induced by protein restriction. Hypertension 47, 982-987. 
 
Torrens C, Brawley L, Barker AC, Itoh S, Poston L & Hanson MA (2003). Maternal 
protein restriction in the rat impairs resistance artery but not conduit artery function in 
pregnant offspring. J Physiol 547, 77-84. 
 
Watkins A, Wilkins A, Osmond C, Warner CM, Comiskey M, Hanson M & Fleming, 
TP (2006). The influence of mouse Ped gene expression on postnatal development. J 
Physiol 571, 211-220. 
 
Watkins AJ, Platt D, Papenbrock T, Wilkins A, Eckert JJ, Kwong WY, Osmond C, 
Hanson M & Fleming TP (2007). Mouse embryo culture induces changes in postnatal 
phenotype including raised systolic blood pressure. Proc Natl Acad Sci USA 104, 
5449-5454. 
 
 
 
 22 
Watkins AJ, Ursell E, Panton R, Papenbrock T, Hollis L, Cunningham C, Wilkins A, 
Perry VH, Sheth B, Kwong WY, Eckert JJ, Wild AE, Hanson MA, Osmond C & 
Fleming TP (2008). Adaptive Responses by Mouse Early Embryos to Maternal Diet 
Protect Fetal Growth but Predispose to Adult Onset Disease. Biol Reprod 78, 299-
306.  
 
Woods LL, Ingelfinger JR & Rasch R (2005). Modest maternal protein restriction 
fails to program adult hypertension in female rats. Am J Physiol Regul Integr Comp 
Physiol 289, R1131-R1136. 
 
Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, 
Broadbent PJ, Robinson JJ, Wilmut I & Sinclair KD (2001). Epigenetic change in 
IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet 27, 
153-154. 
 
Zandi-Nejad K, Luyckx VA & Brenner BM (2006). Adult hypertension and kidney 
disease: the role of fetal programming. Hypertension 47, 502-508. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 23 
Figure legends 
Figure 1 
Maternal low protein diet (LPD) during oocyte maturation causes an elevation in birth 
weight in male offspring at a trend level (P =0.073) independent of maternal origin 
and gestational litter size. Mean (± SEM) for males (n = 82-96) and females (n = 101-
105) from 19 litters per treatment group.     
 
Figure 2 
Maternal LPD during oocyte maturation has no effect on postnatal growth. Mean (± 
SEM) body mass for (A) male (n = 42-60) and (B) female (n = 48-57) offspring for 3-
28 weeks from 19 litters per treatment group.  
 
Figure 3 
Maternal LPD during oocyte maturation leads to changes in postnatal behaviour. 
Mean open field behaviour for (A) male (n = 52-59 per treatment) and (B) female (n = 
54-57) offspring from 19 litters. * denotes P <0.01 independent of maternal origin and 
gestational litter size. ‡ denotes difference at a trend level (P = 0.071). 
 
Figure 4 
Maternal LPD during oocyte maturation induces an elevation in postnatal SBP. Mean  
(± SEM) SBP of (A) male (n = 45-59 per treatment) and (B) female (n = 51-56) 
offspring from 19 litters per treatment group. * denotes P <0.05 independent of  
maternal origin and gestational litter size. ‡ denotes difference at a trend level (P = 
0.09). 
 
Figure 5 
Maternal LPD during oocyte maturation reduces the vasoreactivity of isolated male 
offspring mesenteric arteries at 22 weeks. Cumulative additions of (A) phenylephrine 
(PE) and, after pre-constriction with PE of the vasodilators (B) acetylcholine (ACh), 
(C) isoprenaline (ISO) and (D) sodium nitroprusside (SNP). No difference is observed 
in responsiveness to PE or SNP between treatments, however, LPD arteries display 
attenuated responses to ACh and ISO when compared to NPD arteries. Values are 
 24 
mean ± SEM; n = 7 males, each from different litters, from each treatment group; *P 
<0.015. 
 
Figure 6 
Maternal LPD during oocyte maturation alters the correlation between organ:body 
weight ratios and Life SBP in offspring. (A, B) LPD males have a positive correlation 
(solid line) between both left and right kidney:body weight ratio and Life SBP (P 
<0.015) which differs from NPD males (dashed line, P <0.015). (C) LPD males have 
a positive correlation (solid line) between heart:body weight ratio and Life SBP (P 
=0.004) which differed from that of NPD males (dashed line, P =0.05). All 
differences were independent of maternal origin and gestational litter size. 
 
Figure 7 
Maternal LPD during oocyte maturation increases kidney mean glomerular number 
(GN) in female LPD offspring at 28 weeks. (A) GN in whole left kidney and GN/gm 
kidney mass and GN/cm3 kidney tissue. Values are mean ± SEM, n = 6 kidneys per 
treatment, *P <0.05 independent of maternal origin and gestational litter size. ‡P = 
0.091.
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Table 1. Litter size and birth criteria (± SEM) of offspring from LPD and NPD 
treatment groups. 
 
    Litter            Gestation                    Litter                   Offspring             Male/female                 
                         number         length, days             size at birth               number                   ratio                  
 
      NPD             19                      20                    10.6 ± 0.366                  201                 1.341 ± 0.403      
      LPD              19                     20                   11.12 ± 0.621                  211                 0.996 ± 0.114     
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Table 2.  Mean organ weight (g) and organ:body weight ratio of (A) male (n = 27-42 per treatment) and (B) female (n = 30-39 per treatment) 
offspring. * denotes P = 0.031 independent of maternal origin and litter size; ‡ denotes difference at a trend level P <0.075. 
(A) Male  
Organ weights (g) 
                                 Liver       Left Kidney         Right Kidney   Heart                  Lung                      Brain    Cerebellum   
 
NPD    2.246 ± 0.044         0.330 ± 0.008         0.341 ± 0.009         0.220 ± 0.004         0.219 ± 0.005         0.455 ± 0.005         0.056 ± 0.002             
LPD    2.172 ± 0.063         0.323 ± 0.011          0.34  ± 0.011         0.218 ± 0.004         0.215 ± 0.005         0.458 ± 0.005         0.058 ± 0.001 
 
Organ:body weight ratio (x 100) 
                               Liver       Left Kidney         Right Kidney   Heart                  Lung                      Brain    Cerebellum   
 
NPD                  4.780 ± 0.053         0.702 ± 0.014         0.725 ± 0.017         0.469 ± 0.008         0.468 ± 0.012         0.977 ± 0.0017         0.120 ± 0.003           
LPD     4.740 ± 0.138         0.706 ± 0.025         0.734 ± 0.026         0.479 ± 0.013         0.473 ± 0.014         1.010 ± 0.028           0.127 ± 0.004  
  
(B) Female  
Organ weights (g) 
                                         Liver       Left Kidney         Right Kidney   Heart                  Lung                      Brain    Cerebellum   
 
NPD                 1.824 ± 0.05          0.197 ± 0.006           0.204 ± 0.004         0.176 ± 0.003         0.196 ± 0.005         0.471 ± 0.009         0.058 ± 0.001    
LPD    1.833 ± 0.03          0.189 ± 0.003           0.192 ± 0.003‡       0.174 ± 0.003         0.197 ± 0.004         0.466 ± 0.001        0.058 ± 0.001  
 
Organ:body weight ratio (x100) 
                                 Liver        Left Kidney          Right Kidney   Heart                    Lung                       Brain     Cerebellum   
 
NPD    4.500 ± 0.080         0.494 ± 0.015         0.510 ± 0.015         0.442 ± 0.012         0.493 ± 0.011         1.200 ± 0.032         0.148 ± 0.004 
LPD    4.410 ± 0.143         0.455 ± 0.016‡       0.462 ± 0.017*       0.422 ± 0.016         0.475 ± 0.017         1.170 ± 0.031          0.146 ± 0.004  
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Figure 3 
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Figure 5 
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Figure 6 
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Figure 7 
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